Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Coupang, Inc.CPNG · Entity 3157 | Director | June 11, 2026 | June 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Coupang, Inc.
Report date June 11, 2026 · Filed June 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 96,164 |
Reported balance
After 2026-06-11 transaction · row 1
1 source rowRow 1 · 2026-06-11 · Grant · Acquired 17,391 · Balance 96,164 F1: Represents the annual director retainer grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. The RSUs will vest on the earlier of (i) the date of the next annual meeting of stockholders of the Issuer following June 11, 2026 or (ii) June 11, 2027, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 55,310,977 |
Reported balance
Holding disclosure · report date 2026-06-11 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 55,310,977 F2: The securities reported herein are held by certain funds and accounts for which Greenoaks LLC ("Greenoaks") serves as the investment adviser and related persons or entities, including certain estate planning vehicles of the Reporting Person, who serves as a Managing Partner of Greenoaks. Accordingly, the Reporting Person may be attributed beneficial ownership of the reported securities, but he disclaims such beneficial ownership except to the extent of his pecuniary interest, if any, therein. This Statement shall not be deemed to be an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the annual director retainer grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. The RSUs will vest on the earlier of (i) the date of the next annual meeting of stockholders of the Issuer following June 11, 2026 or (ii) June 11, 2027, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.
F2: The securities reported herein are held by certain funds and accounts for which Greenoaks LLC ("Greenoaks") serves as the investment adviser and related persons or entities, including certain estate planning vehicles of the Reporting Person, who serves as a Managing Partner of Greenoaks. Accordingly, the Reporting Person may be attributed beneficial ownership of the reported securities, but he disclaims such beneficial ownership except to the extent of his pecuniary interest, if any, therein. This Statement shall not be deemed to be an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CLOVER HEALTH INVESTMENTS, CORP. /DE
Report date November 22, 2021 · Filed November 24, 2021
Jointly reported with GREENOAKS LLC, PERETZ BENJAMIN
Section 16 reporting ended · disclosed 2021-11-24. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee footnote | 25,754,556 |
Reported balance
After 2021-11-22 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-11-22 · Other · Disposed 24,333,120 · Balance 25,754,556 F1: This transaction represents a pro-rata in-kind distribution by certain funds and accounts to which Greenoaks Capital Partners LLC ("Greenoaks Capital") serves as the investment adviser. All shares of Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events, including upon a transfer, other than certain permitted transfers, as set forth in the Issuer's certificate of incorporation, which is filed as Exhibit 3.1 to the Issuer's Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on January 12, 2021. Accordingly, such shares automatically converted in connection with the receipt of such distribution by the distributees. Subject to such automatic conversion provisions, the shares of Class B Common Stock have no expiration date. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock. F2: The securities reported herein are held by certain funds and accounts to which Greenoaks Capital serves as the investment adviser and related persons or entities. Neil Mehta and Benjamin Peretz serve as Managing Directors of Greenoaks Capital. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction represents a pro-rata in-kind distribution by certain funds and accounts to which Greenoaks Capital Partners LLC ("Greenoaks Capital") serves as the investment adviser. All shares of Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events, including upon a transfer, other than certain permitted transfers, as set forth in the Issuer's certificate of incorporation, which is filed as Exhibit 3.1 to the Issuer's Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on January 12, 2021. Accordingly, such shares automatically converted in connection with the receipt of such distribution by the distributees. Subject to such automatic conversion provisions, the shares of Class B Common Stock have no expiration date. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock.
F2: The securities reported herein are held by certain funds and accounts to which Greenoaks Capital serves as the investment adviser and related persons or entities. Neil Mehta and Benjamin Peretz serve as Managing Directors of Greenoaks Capital.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 13, 2021 Filed Aug 18, 2021 01:48 UTC | Coupang, Inc. CPNG · Entity 3157 | OtherClass A Common Stock | 57,693,991 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000902664-21-003924 · ownership.xml · nonDerivative · entry 1 GREENOAKS CAPITAL PARTNERS LLC · CIK 0001840735 · Director · 10% owner · See Remarks MEHTA NEIL · CIK 0001840890 · Director · 10% owner PERETZ BENJAMIN · CIK 0001840428 · 10% owner · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 223,428,661 F1 · kind: This transaction represents an in-kind distribution by certain funds and accounts to which Greenoaks Capital Partners LLC ("Greenoaks Capital") serves as the investment adviser. F1 · price: This transaction represents an in-kind distribution by certain funds and accounts to which Greenoaks Capital Partners LLC ("Greenoaks Capital") serves as the investment adviser. F4 · balance_after: Excludes 4,564,571 shares of Class A Common Stock which were not required to be included in the Form 3 filed by the Reporting Persons with the SEC on March 10, 2021 and the Form 4 filed by the Reporting Persons with the SEC on March 17, 2021, which are held by GCM-IFA, LP, and is not a Reporting Person for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. F2 · ownership.nature: The securities reported herein are held by certain funds and accounts to which Greenoaks Capital serves as the investment adviser and related persons or entities, including the Reporting Persons and by Greenoaks Capital Management LLC. Neil Mehta and Benjamin Peretz serve as Managing Directors of Greenoaks Capital. Neil Mehta is a director of the issuer. F3 · ownership.nature: Each Reporting Person disclaims beneficial ownership in the securities reported herein except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| July 06, 2021 Filed Jul 9, 2021 00:35 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | OtherClass B Common Stock · Derivative | 21,463,951 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000902664-21-003395 · ownership.xml · derivative · entry 1 GREENOAKS CAPITAL PARTNERS LLC · CIK 0001840735 · 10% owner MEHTA NEIL · CIK 0001840890 · 10% owner PERETZ BENJAMIN · CIK 0001840428 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 74,867,387 Underlying: Class A Common Stock · 21,463,951 shares Expires not disclosed F1 · derivative.exercise_price: This transaction represents a pro-rata in-kind distribution by certain funds and accounts to which Greenoaks Capital Partners LLC ("Greenoaks Capital") serves as the investment adviser. All shares of Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events, including upon a transfer, other than certain permitted transfers, as set forth in the Issuer's certificate of incorporation, which is filed as Exhibit 3.1 to the Issuer's Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on January 12, 2021. Accordingly, such shares automatically converted in connection with the receipt of such distribution by the distributees. Subject to such automatic conversion provisions, the shares of Class B Common Stock have no expiration date. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock. F1 · kind: This transaction represents a pro-rata in-kind distribution by certain funds and accounts to which Greenoaks Capital Partners LLC ("Greenoaks Capital") serves as the investment adviser. All shares of Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events, including upon a transfer, other than certain permitted transfers, as set forth in the Issuer's certificate of incorporation, which is filed as Exhibit 3.1 to the Issuer's Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on January 12, 2021. Accordingly, such shares automatically converted in connection with the receipt of such distribution by the distributees. Subject to such automatic conversion provisions, the shares of Class B Common Stock have no expiration date. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock. F1 · shares: This transaction represents a pro-rata in-kind distribution by certain funds and accounts to which Greenoaks Capital Partners LLC ("Greenoaks Capital") serves as the investment adviser. All shares of Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events, including upon a transfer, other than certain permitted transfers, as set forth in the Issuer's certificate of incorporation, which is filed as Exhibit 3.1 to the Issuer's Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on January 12, 2021. Accordingly, such shares automatically converted in connection with the receipt of such distribution by the distributees. Subject to such automatic conversion provisions, the shares of Class B Common Stock have no expiration date. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock. F1 · price: This transaction represents a pro-rata in-kind distribution by certain funds and accounts to which Greenoaks Capital Partners LLC ("Greenoaks Capital") serves as the investment adviser. All shares of Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events, including upon a transfer, other than certain permitted transfers, as set forth in the Issuer's certificate of incorporation, which is filed as Exhibit 3.1 to the Issuer's Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on January 12, 2021. Accordingly, such shares automatically converted in connection with the receipt of such distribution by the distributees. Subject to such automatic conversion provisions, the shares of Class B Common Stock have no expiration date. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock. F1 · derivative.exercise_date: This transaction represents a pro-rata in-kind distribution by certain funds and accounts to which Greenoaks Capital Partners LLC ("Greenoaks Capital") serves as the investment adviser. All shares of Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events, including upon a transfer, other than certain permitted transfers, as set forth in the Issuer's certificate of incorporation, which is filed as Exhibit 3.1 to the Issuer's Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on January 12, 2021. Accordingly, such shares automatically converted in connection with the receipt of such distribution by the distributees. Subject to such automatic conversion provisions, the shares of Class B Common Stock have no expiration date. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock. F1 · derivative.expiration_date: This transaction represents a pro-rata in-kind distribution by certain funds and accounts to which Greenoaks Capital Partners LLC ("Greenoaks Capital") serves as the investment adviser. All shares of Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events, including upon a transfer, other than certain permitted transfers, as set forth in the Issuer's certificate of incorporation, which is filed as Exhibit 3.1 to the Issuer's Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on January 12, 2021. Accordingly, such shares automatically converted in connection with the receipt of such distribution by the distributees. Subject to such automatic conversion provisions, the shares of Class B Common Stock have no expiration date. Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock. F2 · ownership.nature: The securities reported herein are held by certain funds and accounts to which Greenoaks Capital serves as the investment adviser and related persons or entities. Neil Mehta and Benjamin Peretz serve as Managing Directors of Greenoaks Capital. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 23:55 UTC | Coupang, Inc. CPNG · Entity 3157 | Grant2018 Convertible Notes · Derivative | 1 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000902664-21-001967 · ownership.xml · derivative · entry 2 GREENOAKS CAPITAL PARTNERS LLC · CIK 0001840735 · Director · 10% owner · See Remarks MEHTA NEIL · CIK 0001840890 · Director · 10% owner PERETZ BENJAMIN · CIK 0001840428 · 10% owner · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Class A Common Stock · 147,186,002 shares Expires not disclosed F3 · derivative.exercise_price: The outstanding principal and accrued interest on the 2018 Convertible Notes was automatically converted into Class A Common Stock upon the closing of the issuer's initial public offering. The conversion price was $3.70 per share. F3 · shares: The outstanding principal and accrued interest on the 2018 Convertible Notes was automatically converted into Class A Common Stock upon the closing of the issuer's initial public offering. The conversion price was $3.70 per share. F3 · price: The outstanding principal and accrued interest on the 2018 Convertible Notes was automatically converted into Class A Common Stock upon the closing of the issuer's initial public offering. The conversion price was $3.70 per share. F3 · derivative.exercise_date: The outstanding principal and accrued interest on the 2018 Convertible Notes was automatically converted into Class A Common Stock upon the closing of the issuer's initial public offering. The conversion price was $3.70 per share. F3 · derivative.expiration_date: The outstanding principal and accrued interest on the 2018 Convertible Notes was automatically converted into Class A Common Stock upon the closing of the issuer's initial public offering. The conversion price was $3.70 per share. F1 · ownership.nature: The securities reported herein are held by certain funds and accounts to which Greenoaks Capital Partners LLC ("Greenoaks Capital") serves as the investment adviser or by Greenoaks Capital Management LLC. Neil Mehta and Benjamin Peretz serve as Managing Directors of Greenoaks Capital. Neil Mehta is a director of the issuer. F2 · ownership.nature: Each Reporting Person disclaims beneficial ownership in the securities reported herein except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 23:55 UTC | Coupang, Inc. CPNG · Entity 3157 | GrantClass A Common Stock | 147,186,002 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000902664-21-001967 · ownership.xml · nonDerivative · entry 1 GREENOAKS CAPITAL PARTNERS LLC · CIK 0001840735 · Director · 10% owner · See Remarks MEHTA NEIL · CIK 0001840890 · Director · 10% owner PERETZ BENJAMIN · CIK 0001840428 · 10% owner · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 285,687,223 F3 · kind: The outstanding principal and accrued interest on the 2018 Convertible Notes was automatically converted into Class A Common Stock upon the closing of the issuer's initial public offering. The conversion price was $3.70 per share. F3 · price: The outstanding principal and accrued interest on the 2018 Convertible Notes was automatically converted into Class A Common Stock upon the closing of the issuer's initial public offering. The conversion price was $3.70 per share. F1 · ownership.nature: The securities reported herein are held by certain funds and accounts to which Greenoaks Capital Partners LLC ("Greenoaks Capital") serves as the investment adviser or by Greenoaks Capital Management LLC. Neil Mehta and Benjamin Peretz serve as Managing Directors of Greenoaks Capital. Neil Mehta is a director of the issuer. F2 · ownership.nature: Each Reporting Person disclaims beneficial ownership in the securities reported herein except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.